Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy. - Bishara I; Cosgrove PA; Majumdar S; Egelston CA; Flores OC; Nakamura B; Ruel N; Frankel PH; Yost SE; Chang S; Jung A; Cristea M; et al. (NPJ precision oncology, 2025)